Commodore Capital LP - 30 Jun 2025 SCHEDULE 13G/A Report for Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share (ELVN)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
Enliven Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
ELVN
Shares outstanding
60,837,949 shares
Disclosed Ownership
6,022,957 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 17:06:37 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 9.9% 6,022,957 0 6,022,957 Michael Kramarz Managing Partner
Commodore Capital Master LP 9.9% 6,022,957 0 6,022,957 Michael Kramarz Authoirzed Signatory
Robert Egen Atkinson 9.9% 6,022,957 0 6,022,957 Robert Egen Atkinson Authoirzed Signatory
Michael Kramarz 9.9% 6,022,957 0 6,022,957 Michael Kramarz Authoirzed Signatory